Join our daily newsletter At The Bell to receive exclusive market insights
- Medicinal glove manufacturer Ansell (ANN) has appointed Neil Salmon as CEO and Managing Director, effective September 1
- He will take over from Magnus Nicolin who previously announced his retirement
- Mr Salmon joined Ansell in 2013 as Chief Financial Officer and was appointed president of the company’s Industrial Global Business Unit in 2019
- He has more than 20 years of finance, business development, financial planning and investor relations experience
- Ansell has ended the day a slight 0.72 per cent in the red with shares trading at $39.96
Medicinal glove manufacturer Ansell (ANN) has appointed Neil Salmon as CEO and Managing Director, effective September 1.
He will be taking over from Magnus Nicolin who previously announced his retirement.
“It is a considerable responsibility to lead Ansell at this time of enormous need for our personal protection products worldwide,” Mr Salmon commented.
Mr Salmon joined Ansell in 2013 as Chief Financial Officer and was appointed President of the company’s Industrial Global Business Unit (GBU) in 2019.
He has more than 20 years of finance, business development, financial planning and investor relations experience.
Mr Salmon will continue in his current role until August 31 with a new head of the Industrial GBU to be appointed in due course.
“Neil has the right combination of financial and operational experience and capability for the CEO role at Ansell. He has worked alongside Magnus for many years and was a key contributor to the strategies which transformed Ansell during that time,” Chairman John Bevan said.
“More recently, Neil also led our Industrial GBU with its over 7500 strong manufacturing, marketing and product development workforce located in multiple jurisdictions.”
Ansell has ended the day a slight 0.72 per cent in the red with shares trading at $39.96 in a $5.17 billion market cap.
